Explore the categories so you can find more about your search.

Categorie > Blood / Hematology

Phase II Results For Yale's Early Stage Ovarian Cancer Blood Test 99% Accurate

Categorie : Blood / Hematology
Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced that Yale University has released the results of its Phase II study on a blood test to detect early stage ovarian cancer. Using six biomarkers, this blood test can discriminate between disease-free women and ovarian cancer ...

read more Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced that Yale University has released the results of its Phase II study on a blood test to detect early stage ovarian cancer. Using six biomarkers, this blood test can discriminate between disease-free women and ovarian cancer read more Tue Mar 2008 Tue Mar 2008

FDA Grants Priority Review For Promacta(R) / REVOLADE(R) (eltrombopag)

Categorie : Blood / Hematology
GlaxoSmithKline [NYSE: GSK, LSE: GSK] announced that the United States Food and Drug Administration (FDA) has granted Priority Review for PROMACTA(R) / REVOLADE(R) (eltrombopag) for the short-term treatment of patients with chronic idiopathic thrombocytopenic purpura (ITP). Eltrombopag is an inves ...

read more GlaxoSmithKline [NYSE: GSK, LSE: GSK] announced that the United States Food and Drug Administration (FDA) has granted Priority Review for PROMACTA(R) / REVOLADE(R) (eltrombopag) for the short-term treatment of patients with chronic idiopathic thrombocytopenic purpura (ITP). Eltrombopag is an inves read more Tue Mar 2008 Tue Mar 2008

International Journal Of Hematology To Be Published By Springer

Categorie : Blood / Hematology
Springer and the Japanese Society of Hematology announce a new partnership to publish the International Journal of Hematology. The journal is available (back to 1997) on Springer's online information platform SpringerLink. The journal appears ten times a year and was previously published by Carden J ...

read more Springer and the Japanese Society of Hematology announce a new partnership to publish the International Journal of Hematology. The journal is available (back to 1997) on Springer's online information platform SpringerLink. The journal appears ten times a year and was previously published by Carden J read more Tue Mar 2008 Tue Mar 2008

First US Von Willebrand Disease Clinical Practice Guidelines Issued By NHLBI

Categorie : Blood / Hematology
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, has issued the first clinical guidelines in the United States for the diagnosis and management of von Willebrand Disease (VWD), the most common inherited bleeding disorder. The guidelines include recommendati ...

read more The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, has issued the first clinical guidelines in the United States for the diagnosis and management of von Willebrand Disease (VWD), the most common inherited bleeding disorder. The guidelines include recommendati read more Tue Mar 2008 Tue Mar 2008

Few Sickle Cell Patients Using Generic Treatment To Relieve Pain, NIH Panel Says

Categorie : Blood / Hematology
While there is an inexpensive, generic medication that can stop severe pain and the need for blood transfusions associated with sickle cell disease, few patients receive the treatment, Reuters reports. An NIH consensus panel discussed the issue on Wednesday. ...

read more While there is an inexpensive, generic medication that can stop severe pain and the need for blood transfusions associated with sickle cell disease, few patients receive the treatment, Reuters reports. An NIH consensus panel discussed the issue on Wednesday. read more Tue Mar 2008 Tue Mar 2008

California County Board Of Supervisors Votes To Oppose FDA Policy Barring MSM From Donating Blood

Categorie : Blood / Hematology
The Santa Clara County, Calif., Board of Supervisors on Tuesday voted unanimously to oppose an FDA policy that prohibits men who have sex with men from donating blood, the San Jose Mercury New reports. ...

read more The Santa Clara County, Calif., Board of Supervisors on Tuesday voted unanimously to oppose an FDA policy that prohibits men who have sex with men from donating blood, the San Jose Mercury New reports. read more Tue Mar 2008 Tue Mar 2008

Possible Target To Treat Deadly Bloodstream Infections Found By Researchers

Categorie : Blood / Hematology
Researchers at the University of Illinois at Chicago have discovered a possible target to treat bloodstream bacterial infections.Most bacterial pathogens can invade the bloodstream, which can lead to severe sepsis, a syndrome that kills about 215,000 of the 750,000 people affected in the United Stat ...

read more Researchers at the University of Illinois at Chicago have discovered a possible target to treat bloodstream bacterial infections.Most bacterial pathogens can invade the bloodstream, which can lead to severe sepsis, a syndrome that kills about 215,000 of the 750,000 people affected in the United Stat read more Tue Mar 2008 Tue Mar 2008

Arbios Receives Conditional Approval From The FDA To Initiate Pivotal Clinical Trial For SEPET(TM)

Categorie : Blood / Hematology
Arbios Systems, Inc. (OTC Bulletin Board: ABOS) announced that the Company has received conditional approval from the U.S. Food and Drug Administration ("FDA") of an Investigational Device Exemption ("IDE") to begin the pivotal clinical trial for SEPET(TM), Arbios' extracorporeal (outside the body) ...

read more Arbios Systems, Inc. (OTC Bulletin Board: ABOS) announced that the Company has received conditional approval from the U.S. Food and Drug Administration ( read more Sun Feb 2008 Sun Feb 2008

FDA Licenses New Hemophilia Treatment

Categorie : Blood / Hematology
The U.S. Food and Drug Administration licensed a treatment for hemophilia A, a rare, hereditary blood-clotting disorder that affects approximately 15,000 individuals, almost exclusively males, in the United States.The new treatment, called Xyntha Antihemophilic Factor (Recombinant) Plasma/Albumin Fr ...

read more The U.S. Food and Drug Administration licensed a treatment for hemophilia A, a rare, hereditary blood-clotting disorder that affects approximately 15,000 individuals, almost exclusively males, in the United States.The new treatment, called Xyntha Antihemophilic Factor (Recombinant) Plasma/Albumin Fr read more Sat Feb 2008 Sat Feb 2008

Gen-Probe Submits U.S. Regulatory Application For Additional Approval Of PROCLEIX(R) ULTRIO(R) Blood Screening Assay

Categorie : Blood / Hematology
Gen-Probe Incorporated (Nasdaq: GPRO) has submitted to the U.S. Food and Drug Administration (FDA) a supplemental regulatory application for the additional use of the PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the hepatitis B virus (HBV), the Company announced. The FDA approved the assa ...

read more Gen-Probe Incorporated (Nasdaq: GPRO) has submitted to the U.S. Food and Drug Administration (FDA) a supplemental regulatory application for the additional use of the PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the hepatitis B virus (HBV), the Company announced. The FDA approved the assa read more Sat Feb 2008 Sat Feb 2008

Hemo Concepts To Launch Integrated Blood Conservation Program At Texas Heart Institute

Categorie : Blood / Hematology
Hemo Concepts, Inc. announced its agreement with St. Luke's Episcopal Hospital in Houston, TX, to implement the company's Integrated Blood Conservation Program at the Texas Heart Institute. The Texas Heart Institute was founded by Dr. Denton A. Cooley in 1962 as a nonprofit organization dedicated to ...

read more Hemo Concepts, Inc. announced its agreement with St. Luke's Episcopal Hospital in Houston, TX, to implement the company's Integrated Blood Conservation Program at the Texas Heart Institute. The Texas Heart Institute was founded by Dr. Denton A. Cooley in 1962 as a nonprofit organization dedicated to read more Fri Feb 2008 Fri Feb 2008

CLSI Publishes Guideline For The Collection, Transport, And Processing Of Blood Specimens For Coagulation Assays

Categorie : Blood / Hematology
The reliability and accuracy of coagulation test results depend upon a variety of variables, including anticoagulant volume and concentration, type of tube additive, duration and temperature of specimen storage, and surface of containers used for specimen collection and storage. ...

read more The reliability and accuracy of coagulation test results depend upon a variety of variables, including anticoagulant volume and concentration, type of tube additive, duration and temperature of specimen storage, and surface of containers used for specimen collection and storage. read more Fri Feb 2008 Fri Feb 2008

NIH Hydroxyurea Treatment For Sickle Cell Disease Conference, Feb. 25-27

Categorie : Blood / Hematology
For many patients, the pain and complications associated with sickle cell disease can have a profound impact on their quality of life, ability to work, and long-term health and well-being. Unfortunately, these challenges are often coupled with significant barriers to care. Hydroxyurea is an FDA-appr ...

read more For many patients, the pain and complications associated with sickle cell disease can have a profound impact on their quality of life, ability to work, and long-term health and well-being. Unfortunately, these challenges are often coupled with significant barriers to care. Hydroxyurea is an FDA-appr read more Fri Feb 2008 Fri Feb 2008

Pyng Medical Receives US FDA Clearance

Categorie : Blood / Hematology
Pyng Medical Corp. (TSX VENTURE:PYT) announced the Company has received Special 510(K) regulatory clearance from the US Food and Drug Administration to market its new and improved version of the award-winning FAST1TM Intraosseous (IO) Infusion System throughout the US, effective immediately. FAST1T ...

read more Pyng Medical Corp. (TSX VENTURE:PYT) announced the Company has received Special 510(K) regulatory clearance from the US Food and Drug Administration to market its new and improved version of the award-winning FAST1TM Intraosseous (IO) Infusion System throughout the US, effective immediately. FAST1T read more Fri Feb 2008 Fri Feb 2008

University Of Leicester Scientists Develop New Techniques For Detecting Harmful Blood Clots/Air Bubbles In Arteries

Categorie : Blood / Hematology
New techniques for detecting emboli (harmful blood clots/air bubbles in arteries) developed at the University of Leicester have played a major role in dramatically reducing stroke rates after carotid endarterectomy. This is an operation designed to remove narrowings in the main arteries supplying ...

read more New techniques for detecting emboli (harmful blood clots/air bubbles in arteries) developed at the University of Leicester have played a major role in dramatically reducing stroke rates after carotid endarterectomy. This is an operation designed to remove narrowings in the main arteries supplying read more Fri Feb 2008 Fri Feb 2008

High Percentage Of Blood Disorder Patients Were Cured Or Achieved Remission When Treated With Stem Cells From Their Own Cord Blood Or A Sibling's

Categorie : Blood / Hematology
In a retrospective review of blood disorder patients treated with stem cells from their own cord blood (autologous transplant) or from the cord blood of a sibling (allogeneic-related transplant), the majority of the patients were cured or achieved remission from their disease, according to a report ...

read more In a retrospective review of blood disorder patients treated with stem cells from their own cord blood (autologous transplant) or from the cord blood of a sibling (allogeneic-related transplant), the majority of the patients were cured or achieved remission from their disease, according to a report read more Fri Feb 2008 Fri Feb 2008

Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance The Accuracy Of Molecular Tests For Warfarin Metabolism

Categorie : Blood / Hematology
Following the exclusive license of the warfarin biomarker, 4F2, by the Marshfield Clinic to Osmetech in November 2007, the Marshfield Clinic Research Foundation, led by Michael D. Caldwell, M.D., Ph.D., has an article published in the peer-reviewed journal, Blood Online, entitled "CYP4F2 genetic var ...

read more Following the exclusive license of the warfarin biomarker, 4F2, by the Marshfield Clinic to Osmetech in November 2007, the Marshfield Clinic Research Foundation, led by Michael D. Caldwell, M.D., Ph.D., has an article published in the peer-reviewed journal, Blood Online, entitled read more Fri Feb 2008 Fri Feb 2008

The Key To Curing Hemophilia A May Lie In Transplanted Cells

Categorie : Blood / Hematology
Scientists at the Albert Einstein College of Medicine of Yeshiva University have shown for the first time that transplanted cells can cure hemophilia A (the most common form of the disease) in an animal model. Their study appears online February 14 in the Journal of Clinical Investigation.Hemophilia ...

read more Scientists at the Albert Einstein College of Medicine of Yeshiva University have shown for the first time that transplanted cells can cure hemophilia A (the most common form of the disease) in an animal model. Their study appears online February 14 in the Journal of Clinical Investigation.Hemophilia read more Fri Feb 2008 Fri Feb 2008

Clavis Pharma Successfully Completes Clinical Phase I Study In Haematology

Categorie : Blood / Hematology
Clavis Pharma (OSE: CLAVIS) announced that an important milestone has been reached in its haematology program with ELACYT(TM). The phase I part of the ongoing clinical phase I/II study within haematological cancers has been successfully completed. The maximal tolerated dose (MTD) has been determined ...

read more Clavis Pharma (OSE: CLAVIS) announced that an important milestone has been reached in its haematology program with ELACYT(TM). The phase I part of the ongoing clinical phase I/II study within haematological cancers has been successfully completed. The maximal tolerated dose (MTD) has been determined read more Tue Feb 2008 Tue Feb 2008

Award To Pursue Research Opportunities In US Won By European Blood Researchers

Categorie : Blood / Hematology
The European Hematology Association (EHA) and the American Society of Hematology (ASH) have selected Lapo Alinari, MD, and Serena Kimi Perna, MD, as the recipients of the second annual EHA-ASH International Fellowship Award, which was established to help strengthen ties between American and European ...

read more The European Hematology Association (EHA) and the American Society of Hematology (ASH) have selected Lapo Alinari, MD, and Serena Kimi Perna, MD, as the recipients of the second annual EHA-ASH International Fellowship Award, which was established to help strengthen ties between American and European read more Tue Feb 2008 Tue Feb 2008

<<< previous | 4 | 5 | 6 | 7 | 8 | 9 | 10 next >>>



     


Custom Search